At Sauad Farmacêutica, we manufacture commercial solid and semisolid formulations. Our global manufacturing network consists of 6 state-of-the-art manufacturing sites (API & Finished Dose). We are a trusted manufacturing partner to leading biotech pharmaceutical companies. Our scalability is defined to serve customers at every stage of the drug lifecycle from manufacturing perspective. Our manufacturing operations are focused on producing generics, branded generics, oncology and over-the-counter (OTC) products.
Sauad Farmacêutica has a global manufacturing network for a wide variety of dosage forms. Our global manufacturing network consists of manufacturing units in USA, Brazil, India, Japan along with additional units in UAE ensuring commercial operations in over 50 international markets.
To know more about our manufacturing network visit us https://www.neopharma.com/finish.html
Our world-class API manufacturing facility in Hyderabad, India, is capable of handling new, complex and hazardous reactions. Sauad Farmacêutica supplies NCEs, cGMP intermediates and KSMs to global innovators. It is equipped with flexible, versatile and advanced infrastructure, tailored to fit any complex chemistry molecules. The manufacturing facilities comply with current Good Manufacturing Practices (cGMP) requirements and are successfully approved by regulatory agencies.
Our expertise in intellectual property and regulatory affairs helps us consistently deliver the highest quality API's that meet or exceed regulatory standards.